EcoDrugPlus

Ret Proto-Oncogene

Ensembl ID : ENSPLOG00000017480
Gene Symbol: RET
4 Cross references
204 Possible Orthologues:

Retinoic Acid Receptor Alpha

Ensembl ID : ENSPLOG00000012621
Gene Symbol: RARA
4 Cross references
331 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSPLOG00000007152
Gene Symbol: RARB
4 Cross references
450 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSPLOG00000004210
Gene Symbol: RARG
2 Cross references
445 Possible Orthologues:

Retinoid X Receptor Alpha

Ensembl ID : ENSPLOG00000021054
Gene Symbol: RXRA
2 Cross references
244 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSPLOG00000009094
Gene Symbol: RXRB
4 Cross references
234 Possible Orthologues:

Retinoid X Receptor Gamma

Ensembl ID : ENSPLOG00000017780
Gene Symbol: RXRG
2 Cross references
274 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSPLOG00000014251
Gene Symbol: RPL10A
4 Cross references
204 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSPLOG00000007468
Gene Symbol: RPL11
4 Cross references
146 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSPLOG00000010753
Gene Symbol: RPL13
4 Cross references
266 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSPLOG00000008524
Gene Symbol: RPL18
4 Cross references
342 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSPLOG00000007431
Gene Symbol: RPL19
4 Cross references
239 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).